Collections:
Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, ∼1129👍, 0💬
Related Topics:
Popular Posts:
Paper Summary: Title: Alignment options for total knee arthroplasty: A systematic review Author(s): ...
Paper Summary: Title: Women's empowerment and household food security in Ghana Author(s): Essilfie, ...
How to retrieve a list of DOIs with api.datacite.org/dois? If you want to retrieve a list of DOIs yo...
Paper Summary: Title: Internet Gaming Addiction: A Systematic Review of Empirical Research Author(s)...
Paper Summary: Title: Updating Phylogeny of Mitochondrial DNA Macrohaplogroup M in India: Dispersal ...
